The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the U.S. Food Drug Administration and will be distributed in the United States by a Greensboro-based company.
The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the FDA and will be distributed in the US by Greensboro-based Carolina Liquid Chemistries.
Carolina Liquid Chemistries Corp. of Greensboro has signed a semi-exclusive agreement to distribute a portable chemistry analyzer for the U.S. veterinary market.